| Oligomeric structure of the chemokine CCL5/RANTES from NMR, MS, and SAXS data X Wang, C Watson, JS Sharp, TM Handel, JH Prestegard Structure 19 (8), 1138-1148, 2011 | 109 | 2011 |
| Pulsed electron beam water radiolysis for submicrosecond hydroxyl radical protein footprinting C Watson, I Janik, T Zhuang, O Charvátová, RJ Woods, JS Sharp Analytical chemistry 81 (7), 2496-2505, 2009 | 91 | 2009 |
| Systems-based proteomics to resolve the biology of Alzheimer’s disease beyond amyloid and tau S Rayaprolu, L Higginbotham, P Bagchi, CM Watson, T Zhang, AI Levey, ... Neuropsychopharmacology 46 (1), 98-115, 2021 | 89 | 2021 |
| Simultaneous measurement of tabun, sarin, soman, cyclosarin, VR, VX, and VM adducts to tyrosine in blood products by isotope dilution UHPLC-MS/MS BS Crow, BG Pantazides, J Quiñones-González, JW Garton, MD Carter, ... Analytical chemistry 86 (20), 10397-10405, 2014 | 62 | 2014 |
| An enhanced butyrylcholinesterase method to measure organophosphorus nerve agent exposure in humans BG Pantazides, CM Watson, MD Carter, BS Crow, JW Perez, TA Blake, ... Analytical and bioanalytical chemistry 406, 5187-5194, 2014 | 61 | 2014 |
| Conformational analysis of therapeutic proteins by hydroxyl radical protein footprinting C Watson, JS Sharp The AAPS journal 14, 206-217, 2012 | 55 | 2012 |
| Direct quantitation of methyl phosphonate adducts to human serum butyrylcholinesterase by immunomagnetic-UHPLC-MS/MS MD Carter, BS Crow, BG Pantazides, CM Watson, JD Thomas, TA Blake, ... Analytical chemistry 85 (22), 11106-11111, 2013 | 44 | 2013 |
| Cerebrospinal fluid proteomics define the natural history of autosomal dominant Alzheimer’s disease ECB Johnson, S Bian, RU Haque, EK Carter, CM Watson, BA Gordon, ... Nature medicine 29 (8), 1979-1988, 2023 | 39 | 2023 |
| Urine oligosaccharide screening by MALDI-TOF for the identification of NGLY1 deficiency PL Hall, C Lam, JJ Alexander, G Asif, GT Berry, C Ferreira, HH Freeze, ... Molecular genetics and metabolism 124 (1), 82-86, 2018 | 36 | 2018 |
| Enhanced stability of blood matrices using a dried sample spot assay to measure human butyrylcholinesterase activity and nerve agent adducts JW Perez, BG Pantazides, CM Watson, JD Thomas, TA Blake, ... Analytical chemistry 87 (11), 5723-5729, 2015 | 32 | 2015 |
| Quantitative proteomics of cerebrospinal fluid from African Americans and Caucasians reveals shared and divergent changes in Alzheimer’s disease ES Modeste, L Ping, CM Watson, DM Duong, EB Dammer, ECB Johnson, ... Molecular neurodegeneration 18 (1), 48, 2023 | 23 | 2023 |
| Quantitation of ortho‐cresyl phosphate adducts to butyrylcholinesterase in human serum by immunomagnetic‐UHPLC‐MS/MS D Johnson, MD Carter, BS Crow, SL Isenberg, LA Graham, HA Erol, ... Journal of Mass Spectrometry 50 (4), 683-692, 2015 | 21 | 2015 |
| Quantitative mass spectrometry analysis of cerebrospinal fluid protein biomarkers in Alzheimer’s disease CM Watson, EB Dammer, L Ping, DM Duong, E Modeste, EK Carter, ... Scientific Data 10 (1), 261, 2023 | 19 | 2023 |
| A protein panel in cerebrospinal fluid for diagnostic and predictive assessment of Alzheimer’s disease R Haque, CM Watson, J Liu, EK Carter, DM Duong, JJ Lah, AP Wingo, ... Science translational medicine 15 (712), eadg4122, 2023 | 13 | 2023 |
| Profiling cholinesterase adduction: A high-throughput prioritization method for organophosphate exposure samples MD Carter, BS Crow, BG Pantazides, CM Watson, BR DeCastro, ... Journal of biomolecular screening 19 (2), 325-330, 2014 | 11 | 2014 |
| Quantitative mass spectrometry analysis of cerebrospinal fluid biomarker proteins reveals stage-specific changes in Alzheimer’s disease CM Watson, EB Dammer, L Ping, DM Duong, E Modeste, EK Carter, ... medRxiv, 2022.08. 30.22279370, 2022 | 4 | 2022 |
| Predictors of cognitive decline in healthy middle-aged individuals with asymptomatic Alzheimer’s disease R Tandon, L Zhao, CM Watson, M Elmor, C Heilman, K Sanders, ... Research Square, 2023 | 1 | 2023 |
| Plasma pTau217 Predicts AD and Disease Progression in a Diverse Cohort JJ Lah, BR Roberts, CM Watson, ECB Johnson, CM Hales, D Qiu, ... Alzheimer's Association International Conference, 2024 | | 2024 |
| Integrated Proteomics for Therapeutic Target and Biomarker Discovery in Alzheimer’s Disease NT Seyfried, L Ping, LA Higginbotham, EB Dammer, CM Watson, ... Alzheimer's Association International Conference, 2023 | | 2023 |
| Machine Learning to Stratify Asymptomatic Alzheimer’s Disease Progression Risk with Cerebrospinal Fluid Biomarkers R Tandon, CM Watson, NT Seyfried, CS Mitchell, L Zhao, JJ Lah Alzheimer's & Dementia 18, e069445, 2022 | | 2022 |
Nicholas SeyfriedProfessor of Biochemistry, Emory School of Medicine在 emory.edu 的电子邮件经过验证
